Evogene Ltd (EVGN)

Mar 25, 2026

Evogene Ltd Stock Faces Pressure Amid Biotech Sector Volatility and Pipeline Delays in 2026 - AD HOC NEWS

Mar 25, 2026

Mar 23, 2026

Evogene Earnings Call: AI Ambition Meets Cash Reality - TipRanks

Mar 23, 2026

Mar 22, 2026

If You Invested $1,000 in Evogene (EVGN) - Stock Titan

Mar 22, 2026

Mar 20, 2026

EVGN PE Ratio & Valuation, Is EVGN Overvalued - Intellectia AI

Mar 20, 2026

Mar 18, 2026

Evogene (EVGN) director Leon Recanati details share and option holdings - Stock Titan

Mar 18, 2026

Mar 18, 2026

Evogene (EVGN) director Nir details multiple stock option grants in Form 3 - Stock Titan

Mar 18, 2026

Mar 18, 2026

Evogene (EVGN) director details stock option grants and vesting - Stock Titan

Mar 18, 2026

Mar 18, 2026

Evogene (EVGN) chief development officer reports 40,000-share stock option grant - Stock Titan

Mar 18, 2026

Mar 18, 2026

[Form 3] Evogene Ltd. Initial Statement of Beneficial Ownership - Stock Titan

Mar 18, 2026

Mar 18, 2026

Evogene (EVGN) director Sarit Firon details long-dated stock option grants - Stock Titan

Mar 18, 2026

Mar 18, 2026

Evogene (EVGN) CFO details RSU and stock option holdings - Stock Titan

Mar 18, 2026

Mar 18, 2026

Evogene (EVGN) CEO Haviv Ofer details multi-year stock option grants - Stock Titan

Mar 18, 2026

Mar 14, 2026

Evogene Ltd Stock (ISIN: IL0010831684) Faces Biotech Volatility Amid AI-Driven Crop Innovation Push - AD HOC NEWS

Mar 14, 2026

Mar 14, 2026

Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline By GuruFocus - Investing.com Canada

Mar 14, 2026

Mar 13, 2026

Evogene (EVGN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan

Mar 13, 2026

Mar 11, 2026

Evogene outlines ChemPass AI-driven strategy and anticipates new collaborations amid organizational realignment - MSN

Mar 11, 2026

Mar 10, 2026

Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 - Sahm

Mar 10, 2026

Mar 09, 2026

How Evogene uses AI to design drugs, on show at BIO-Europe 2026 - Stock Titan

Mar 09, 2026

Mar 07, 2026

Evogene Ltd. (NASDAQ:EVGN) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 07, 2026

Mar 06, 2026

Evogene Financial Results: Quarterly and Annual ReportNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform

Mar 06, 2026

Mar 06, 2026

Evogene Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 06, 2026

Mar 06, 2026

Evogene: Q4 Earnings Snapshot - theheraldreview.com

Mar 06, 2026

Mar 06, 2026

Evogene earnings missed by $0.20, revenue topped estimates - Investing.com Australia

Mar 06, 2026

Mar 05, 2026

Evogene Q4 2025 Earnings Call Transcript - MarketBeat

Mar 05, 2026

Mar 05, 2026

Why Did EVGN Shares Drop More Than 14% Today? - Stocktwits

Mar 05, 2026

Mar 05, 2026

Earnings call transcript: Evogene’s Q4 2025 highlights restructuring gains - Investing.com

Mar 05, 2026

Mar 05, 2026

Earnings call transcript: Evogene’s Q4 2025 highlights restructuring gains By Investing.com - Investing.com India

Mar 05, 2026

Mar 05, 2026

Evogene Reports Fourth Quarter and Full Year 2025 Financial Results - Sahm

Mar 05, 2026

Mar 05, 2026

Evogene Reports Fourth Quarter and Full Year 2025 Financial Resu - GuruFocus

Mar 05, 2026

Mar 05, 2026

Evogene Reshapes AI-Driven Molecule Business With 2025 Results and Strategic Overhaul - TipRanks

Mar 05, 2026

Mar 05, 2026

EVOGENE ($EVGN) Releases Q4 2025 Earnings - Quiver Quantitative

Mar 05, 2026

Mar 05, 2026

Evogene Earnings Review: Q4 Summary - Benzinga

Mar 05, 2026

Mar 04, 2026

An Overview of Evogene's Earnings - Benzinga

Mar 04, 2026

Mar 03, 2026

Evogene Ltd expected to post a loss of 26 cents a shareEarnings Preview - TradingView

Mar 03, 2026

Mar 02, 2026

EVGN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 02, 2026

Feb 27, 2026

EVGN Should I Buy - Intellectia AI

Feb 27, 2026

Feb 27, 2026

Is Evogene Ltd. stock heavily shortedJuly 2025 Retail & Reliable Trade Execution Plans - mfd.ru

Feb 27, 2026

Feb 26, 2026

Evogene refocuses on AI drug discovery platform ChemPass By Investing.com - Investing.com India

Feb 26, 2026

Feb 26, 2026

Evogene Details 2025 Strategic Refocus Around ChemPass AI and Core Health, Agriculture Markets - The Globe and Mail

Feb 26, 2026

Feb 26, 2026

Evogene refocuses on AI drug discovery platform ChemPass - Investing.com

Feb 26, 2026

Feb 25, 2026

Evogene Releases CEO Letter to Shareholders - Finviz

Feb 25, 2026

Feb 25, 2026

Evogene substantially completed divestment of non-core subsidiaries - marketscreener.com

Feb 25, 2026

Feb 25, 2026

Evogene (EVGN) pivots to ChemPass AI and core health and ag markets - Stock Titan

Feb 25, 2026

Feb 23, 2026

Fund Flows: Does Evogene Ltd have consistent dividend growth2025 Market WrapUp & AI Based Trade Execution Alerts - baoquankhu1.vn

Feb 23, 2026

Feb 23, 2026

Winners Losers: Is ProShares Trust ProShares UltraShort Consumer Staples likely to announce a buybackWeekly Stock Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn

Feb 23, 2026

Feb 21, 2026

CEO Moves: Is Evogene Ltd in a consolidation phaseJuly 2025 PostEarnings & Expert-Curated Trade Recommendations - baoquankhu1.vn

Feb 21, 2026

Feb 19, 2026

Evogene Schedules Fourth Quarter and Full Year 2025 Financial Re - GuruFocus

Feb 19, 2026

Feb 19, 2026

Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release – Company Announcement - Financial Times

Feb 19, 2026

Feb 18, 2026

Evogene and QUT partner on AI-based cancer therapies - Pharmaceutical Business review -

Feb 18, 2026

Feb 17, 2026

Ideas Watch: Is Huntington Ingalls Industries Inc a good stock for dollar cost averaging2025 Price Targets & Entry and Exit Point Strategies - baoquankhu1.vn

Feb 17, 2026